Biotech news
Biotech
The shift towards preventative pharmaceuticals could open new, and highly valuable, markets but it must be strengthened by patent rights, says Sam Andrews, senior paralegal at Powell Gilbert. 24 September 2024
Americas
Biotech’s motion for preliminary injunction to prevent Eylea biosimilar rejected I Regeneron has filed multiple suits over rivals’ copies of aflibercept. 24 September 2024
Americas
Court finds United Therapeutics breached settlement agreement by restricting distribution of cartridges | Sandoz alleged rival hampered launch of generic medication for pulmonary arterial hypertension 17 September 2024
Biotech
Sanofi will be responsible for global commercialisation of the medicine, used to treat neuroendocrine tumours | Pharma giant will pay up to $320m plus royalties to two biotech companies. 13 September 2024
Americas
Biopharma firm sues CSPC for allegedly infringing Onivyde patent issued in August | Suit follows complaint in April asserting eight patents against Conjupro’s product. 27 August 2024
Americas
Judges will not rehear safe harbour case between Edwards and Meril | Medtech company said court’s precedent ‘distorts the market’ for patented products. 22 August 2024
Americas
Swiss biopharma took preemptive legal action against US rival after learning it would be subject to “aggressive” enforcement over therapy | Technology at heart of case treats disruptions to healthy bacterial organisms in human intestinal tract. 13 August 2024
Americas
Massachusetts biotech giants clash as Genzyme alleges Sarepta's Elevidys infringes on key gene therapy patents | Despite the dispute, Elevidys $200M in sales and recent FDA approvals show success. 30 July 2024
Americas
Hongene Biotech challenged ChemGenes’ patent after litigation withdrawn | Judges said all challenged claims were unpatentable. 25 July 2024
Biotech
AI has the potential to revolutionise patent examination but uneven adoption of the technology could undermine fairness in the system, says Matthew Veale of Patsnap. 25 July 2024